[HTML][HTML] Clinical development of demethylating agents in hematology
SC Navada, J Steinmann, M Lübbert… - The Journal of …, 2014 - Am Soc Clin Investig
The term epigenetics refers to the heritable changes in gene expression that are not
associated with a change in the actual DNA sequence. Epigenetic dysregulation is linked to …
associated with a change in the actual DNA sequence. Epigenetic dysregulation is linked to …
Targeting DNA methylation
JPJ Issa, HM Kantarjian - Clinical Cancer Research, 2009 - AACR
Two nucleoside inhibitors of DNA methylation, azacitidine and decitabine, are now standard
of care for the treatment of the myelodysplastic syndrome, a deadly form of leukemia. These …
of care for the treatment of the myelodysplastic syndrome, a deadly form of leukemia. These …
Azacytidine causes complex DNA methylation responses in myeloid leukemia
C Stresemann, I Bokelmann, U Mahlknecht… - Molecular cancer …, 2008 - AACR
Aberrant DNA methylation patterns play an important role in the pathogenesis of
hematologic malignancies. The DNA methyltransferase inhibitors azacytidine and …
hematologic malignancies. The DNA methyltransferase inhibitors azacytidine and …
[HTML][HTML] Demethylating agents in the treatment of cancer
PM Howell Jr, Z Liu, HT Khong - Pharmaceuticals, 2010 - mdpi.com
Gene silencing resulting from aberrant DNA methylation can lead to tumorigenesis.
Therefore, drugs that inhibit or interfere with DNA methylation have been used to reactivate …
Therefore, drugs that inhibit or interfere with DNA methylation have been used to reactivate …
Decitabine—bedside to bench
Y Oki, E Aoki, JPJ Issa - Critical reviews in oncology/hematology, 2007 - Elsevier
PURPOSE OF THE REVIEW: Epigenetic changes marked by DNA methylation are known to
contribute to the malignant transformation of cells by silencing critical genes. Decitabine …
contribute to the malignant transformation of cells by silencing critical genes. Decitabine …
Decitabine and its role in the treatment of hematopoietic malignancies
ER Plimack, HM Kantarjian, JP Issa - Leukemia & lymphoma, 2007 - Taylor & Francis
DNA methylation is responsible for abnormal silencing of many genes, including tumor
suppressor genes, in cancer. Decitabine, an S-phase specific inhibitor of DNA …
suppressor genes, in cancer. Decitabine, an S-phase specific inhibitor of DNA …
The use of hypomethylating agents in the treatment of hematologic malignancies
JE Kihslinger, LA Godley - Leukemia & lymphoma, 2007 - Taylor & Francis
Epigenetic alterations, such as DNA methylation and histone modifications, are abnormal in
cancer cells, and the use of the hypomethylating agents 5-azacitidine and decitabine are …
cancer cells, and the use of the hypomethylating agents 5-azacitidine and decitabine are …
DNA methylation and gene silencing in cancer
SB Baylin - Nature clinical practice Oncology, 2005 - nature.com
Epigenetic changes such as DNA methylation act to regulate gene expression in normal
mammalian development. However, promoter hypermethylation also plays a major role in …
mammalian development. However, promoter hypermethylation also plays a major role in …
DNA methylation as a therapeutic target in hematologic disorders: recent results in older patients with myelodysplasia and acute myeloid leukemia
B Rüter, PW Wijermans, M Lübbert - International journal of hematology, 2004 - Springer
DNA methylation provides a major epigenetic code (besides histone modification) of the
lineage-and developmentspecific genes (such as regulators of differentiation in the …
lineage-and developmentspecific genes (such as regulators of differentiation in the …
DNA methylation and demethylating drugs in myelodysplastic syndromes and secondary leukemias
BACKGROUND AND OBJECTIVES: Methylation of DNA is a common epigenetic
modification that plays an important role in the control of gene expression in mammalian …
modification that plays an important role in the control of gene expression in mammalian …